BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effect of <i>Lactobacillus rhamnosus</i> HN001 and <i>Bifidobacterium longum</i> BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study. ✅
Go to Publication ✅
World journal of gastroenterology (World J Gastroenterol ) Vol: 23 Issue 15 Pages: 2696-2704 Pub: 2017 Apr 21 Epub: Authors Toscano M , De Grandi R , Stronati L , De Vecchi E , Drago L , |
|
|
Effect of Lactobacillus rhamnosus hsryfm 1301 on the Gut Microbiota and Lipid Metabolism in Rats Fed a High-Fat Diet. ✅
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 25 Issue 5 Pages: 687-95 Pub: 2015 May Epub: Authors Chen D , Yang Z , Chen X , Huang Y , Yin B , Guo F , Zhao H , Huang J , Wu Y , Gu R , |
|
|
Effect of Lactobacillus rhamnosus hsryfm 1301 on the Gut Microbiota and Lipid Metabolism in Rats Fed a High-Fat Diet. ✅
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 25 Issue 5 Pages: 687-95 Pub: 2015 May Epub: Authors Chen D , Yang Z , Chen X , Huang Y , Yin B , Guo F , Zhao H , Huang J , Wu Y , Gu R , |
|
|
Limosilactobacillus reuteri and Lacticaseibacillus rhamnosus GG differentially affect gut microbes and metabolites in mice with Treg-deficiency. ✅
Go to Publication ✅
American journal of physiology. Gastrointestinal and liver physiology (Am J Physiol Gastrointest Liver Physiol ) Vol: Issue Pages: Pub: 2021 Mar 31 Epub: 2021 Mar 31 Authors Liu Y , Hoang TK , Taylor CM , Park ES , Freeborn J , Luo M , Roos S , Rhoads JM , |
|
|
Dietary supplementation with Lacticaseibacillus rhamnosus IDCC3201 alleviates sarcopenia by modulating the gut microbiota and metabolites in dexamethasone-induced models. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 15 Issue 9 Pages: 4936-4953 Pub: 2024 May 7 Epub: 2024 May 7 Authors Kang M , Kang M , Yoo J , Lee J , Lee S , Yun B , Song M , Kim JM , Kim HW , Yang J , Kim Y , Oh S , |
|
|
Lacticaseibacillus rhamnosus LS8 Ameliorates Azoxymethane/Dextran Sulfate Sodium-Induced Colitis-Associated Tumorigenesis in Mice via Regulating Gut Microbiota and Inhibiting Inflammation. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: 14 Issue 5 Pages: 947-959 Pub: 2022 Oct Epub: 2022 Jul 5 Authors Wang T , Zheng J , Dong S , Ismael M , Shan Y , Wang X , Lü X , |
|
|
Uremia-Induced Gut Barrier Defect in 5/6 Nephrectomized Mice Is Worsened by Candida Administration through a Synergy of Uremic Toxin, Lipopolysaccharide, and (1?3)-ß-D-Glucan, but Is Attenuated by Lacticaseibacillus rhamnosus L34. ✅
Go to Publication ✅
International journal of molecular sciences (Int J Mol Sci ) Vol: 23 Issue 5 Pages: Pub: 2022 Feb 24 Epub: 2022 Feb 24 Authors Tungsanga S , Panpetch W , Bhunyakarnjanarat T , Udompornpitak K , Katavetin P , Chancharoenthana W , Chatthanathon P , Somboonna N , Tungsanga K , Tumwasorn S , Leelahavanichkul A , |
|
|
Lactobacillus rhamnosus NKU FL1-8 Isolated from Infant Feces Ameliorates the Alcoholic Liver Damage by Regulating the Gut Microbiota and Intestinal Barrier in C57BL/6J Mice. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 13 Pages: Pub: 2024 Jul 4 Epub: 2024 Jul 4 Authors Liu H , Fan D , Wang J , Wang Y , Li A , Wu S , Zhang B , Liu J , Wang S , |
|
|
Lactobacillus rhamnosus Attenuates Cisplatin-Induced Intestinal Mucositis in Mice via Modulating the Gut Microbiota and Improving Intestinal Inflammation. ✅
Go to Publication ✅
Pathogens (Basel, Switzerland) (Pathogens ) Vol: 12 Issue 11 Pages: Pub: 2023 Nov 11 Epub: 2023 Nov 11 Authors Alsholi DM , Yacoub GS , Rehman AU , Ullah H , Khan AI , Deng T , Siddiqui NZ , Alioui Y , Farooqui NA , Elkharti M , Li Y , Wang L , Xin Y , |
|
|
Lactobacillus rhamnosus TR08 Improves Dyslipidemia in Mice Fed with a High Fat Diet by Regulating the Intestinal Microbiota, Reducing Systemic Inflammatory Response, and Promoting Sphingomholipid Metabolism. ✅
Go to Publication ✅
Molecules (Basel, Switzerland) (Molecules ) Vol: 27 Issue 21 Pages: Pub: 2022 Oct 29 Epub: 2022 Oct 29 Authors Feng X , Ding L , Ma G , Zhang Y , Sun Y , Li Z , Tao X , Ali A , Wang D , Wu L , |
|
|
Adjunctive Probiotic Lactobacillus rhamnosus Probio-M9 Administration Enhances the Effect of Anti-PD-1 Antitumor Therapy via Restoring Antibiotic-Disrupted Gut Microbiota. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 12 Issue Pages: 772532 Pub: 2021 Epub: 2021 Dec 14 Authors Gao G , Ma T , Zhang T , Jin H , Li Y , Kwok LY , Zhang H , Sun Z , |
|
|
Lactobacillus rhamnosus LRa05 Ameliorate Hyperglycemia through a Regulating Glucagon-Mediated Signaling Pathway and Gut Microbiota in Type 2 Diabetic Mice. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 69 Issue 31 Pages: 8797-8806 Pub: 2021 Aug 11 Epub: 2021 Aug 2 Authors Wu T , Zhang Y , Li W , Zhao Y , Long H , Muhindo EM , Liu R , Sui W , Li Q , Zhang M , |
|
|
Effect of Lacticaseibacillus rhamnosus IDCC 3201 on irritable bowel syndrome with constipation: a randomized, double-blind, and placebo-controlled trial. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 14 Issue 1 Pages: 22384 Pub: 2024 Sep 27 Epub: 2024 Sep 27 Authors Kwon H , Nam EH , Kim H , Jo H , Bang WY , Lee M , Shin H , Kim D , Kim J , Kim H , Lee J , Jung YH , Yang J , Won DD , Shin M , |
|
|
Protective effects of Lacticaseibacillus rhamnosus Hao9 on dextran sulphate sodium-induced ulcerative colitis in mice. ✅
Go to Publication ✅
Journal of applied microbiology (J Appl Microbiol ) Vol: 133 Issue 3 Pages: 2039-2049 Pub: 2022 Sep Epub: 2022 Jul 20 Authors Han M , Liao W , Si X , Bai C , Gai Z , |
|
|
Clinical Efficacy of Probiotics for Allergic Rhinitis: Results of an Exploratory Randomized Controlled Trial. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 23 Pages: Pub: 2024 Nov 30 Epub: 2024 Nov 30 Authors Lungaro L , Malfa P , Manza F , Costanzini A , Valentini G , Squarzanti DF , Viciani E , Velichevskaya A , Castagnetti A , Barbalinardo M , Gentili D , Cariani A , Ghisellini S , Caputo F , De Giorgio R , Caio G , |
|
|
Lacticaseibacillus rhamnosus LRa05 alleviates cyclophosphamide-induced immunosuppression and intestinal microbiota disorder in mice. ✅
Go to Publication ✅
Journal of food science (J Food Sci ) Vol: 89 Issue 12 Pages: 10003-10017 Pub: 2024 Dec Epub: 2024 Nov 26 Authors Zhu M , Yang L , Kong S , Bai Y , Zhao B , |
|
|
Stachyose in combination with L. rhamnosus GG ameliorates acute hypobaric hypoxia-induced intestinal barrier dysfunction through alleviating inflammatory response and oxidative stress. ✅
Go to Publication ✅
Free radical biology & medicine (Free Radic Biol Med ) Vol: 212 Issue Pages: 505-519 Pub: 2024 Feb 20 Epub: 2024 Jan 9 Authors Ren D , Ding M , Su J , Ye J , He X , Zhang Y , Shang X , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
